Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes

Hepatology

Volumn 54, Issue 5, 2011, Pages 1891-1892

  Houlihan, Diarmaid D ^a,b   Hopkins, Laurence J ^a   Suresh, Shankar X ^a   Armstrong, Matthew J ^a,b   Newsome, Philip N ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ENDOGLIN; HEPATITIS B(E) ANTIGEN; THY 1 ANTIGEN;

CELL DIFFERENTIATION; CELL POPULATION; DISEASE COURSE; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER FAILURE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIXED INFECTION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; VIRUS LOAD;

GENES, VIRAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INTERFERON-ALPHA; MALE; MUTATION; POLYETHYLENE GLYCOLS;

EID: 80055055667     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24722     Document Type: Letter

References (8)

1. Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. HEPATOLOGY 2011; 53: 820-828.
2. Chen CJ, Yang HI, Iloeje UH; REVEAL-HBV Study Group. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. HEPATOLOGY 2009; 49: S72-S84.
3. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-174.
4. Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. HEPATOLOGY 2009; 50: 661-662.
5. Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. HEPATOLOGY 2001; 34: 411-416.
6. Houlihan DD, Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 2008; 135: 438-450.
7. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
8. Prockop DJ, Olson SD. Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood 2007; 109: 3147-3151.